Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Pediatric Blood & Cancer|November 30, 2024
Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of InstrumentsJammbe Musoro, Charlotte Sleurs, Ali Rowsell, et al.Haematologica|December 8, 2018
Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotypeFrédéric Baron, Marian Stevens-Kroef, Michal Kicinski, et al.Cancers|January 11, 2022
Sociodemographic and Medical Determinants of Quality of Life in Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC CLG StudiesCharlotte Sleurs, Jammbe Musoro, Ali Rowsell, et al.Annals of Hematology|June 22, 2018
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trialsFrédéric Baron, Marian Stevens-Kroef, Michal Kicinski, et al.European Journal of Cancer (Oxford, England : 1990)|August 11, 2019
Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trialAlexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, et al.Hemasphere|November 14, 2024
Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B- and T-cell acute lymphoblastic leukemiaCarine Domenech, Michal Kicinski, Barbara De Moerloose, et al.European Journal of Cancer Care|October 26, 2022
Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE studyMelissa Barbati, Michal Kicinski, Stefan Suciu, et al.Human Reproduction (Oxford, England)|November 17, 2021
Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects studyGiovanna Rossi, Michal Kicinski, Stefan Suciu, et al.European Journal of Cancer (Oxford, England : 1990)|May 30, 2020
Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trialAlexander M M Eggermont, Piotr Rutkowski, Caroline Dutriaux, et al.Journal of Cancer Survivorship : Research and Practice|November 28, 2022
Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trialsSidsel J Juul, Sára Rossetti, Michal Kicinski, et al.Pageof 5